UPDATES
Copper-Catalyzed Trifluoromethylation of Aliphatic N-Arylhydrazones
References
zoles: a) G. Zhang, Y. Zhao, H. Ge, Angew. Chem.
2013, 125, 2619; Angew. Chem. Int. Ed. 2013, 52, 2559;
b) R. Vanjari, T. Guntreddi, S. Kumar, K. N. Singh,
Chem. Commun. 2015, 51, 366; cinnolines: c) G.
Zhang, Y. Zhao, H. Ge, Angew. Chem. 2012, 124, 8443;
Angew. Chem. Int. Ed. 2012, 51, 8318.
[1] For recent reviews, see: a) G. Verma, A. Marella, M.
Shaquiquzzaman, M. Akhtar, M. R. Ali, M. M. Alam,
J. Pharm. Bioallied Sci. 2014, 6, 69; b) V. J. Negi, A. K.
Sharma, J. S. Negi, V. Ram, Int. J. Pharm. Chem. 2012,
4, 100.
[2] a) K. R. West, S. Otto, Curr. Drug Discov. Technol.
2005, 2, 123; b) J. B. Matson, S. I. Stupp, Chem.
Commun. 2011, 47, 7962; c) V. Rao N, S. R. Mane, A.
Kishore, J. D. Sarma, R. Shunmugam, Biomacromole-
cules, 2012, 13, 221.
[12] By-products supposedly originate from competitive N-
dealkylation pathways that are not yet fully under-
stood. Further mechanistic studies are currently under-
way to better understand the observed behaviour of ali-
phatic aldehyde N,N-dialkylhydrazones; see the Sup-
porting Information.
[3] For reviews of the rich chemistry of hydrazones, see:
a) R. Lazny, A. Nodzewska, Chem. Rev. 2010, 110,
1386; b) R. Brehme, D. Enders, R. Fernandez, J. M.
Lassaletta, Eur. J. Org. Chem. 2007, 5629.
[4] a) Fluorine in Medicinal Chemistry and Chemical Biol-
ogy, (Ed.: I. Ojima), 2009, Wiley, Chichester; b) S.
Purser, P. R. Moore, S. Swallow, V. Gouverneur, Chem.
Soc. Rev. 2008, 37, 320; c) W. K. Hagmann, J. Med.
Chem. 2008, 51, 4359; d) K. Müller, C. Faeh, F. Dieder-
ich, Science 2007, 317, 1881.
[13] For reviews on the trifluoromethylation of alkenes, see:
a) M. Sodeoka, H. Egami, Angew. Chem. 2014, 126,
8434–8449; Angew. Chem. Int. Ed. 2014, 53, 8294; b) E.
Merino, C. Nevado, Chem. Soc. Rev. 2014, 43, 6598.
[14] CCDC 1052522 contains the supplementary crystallo-
graphic data for this paper. These data can be obtained
free of charge from The Cambridge Crystallographic
see also the Supporting Information.
[15] a) C. A. Veale, J. R. Damewood Jr, G. B. Steelman, C.
Bryant, B. Gomes, J. Williams, J. Med. Chem. 1996, 39,
86; b) G. S. Garrett, S. J. McPhail, K. Tornheim, P. E.
Correa, J. M. McIver, Bioorg. Med. Chem. Lett. 1999, 9,
301; c) R. R. Frey, C. K. Wada, R. B. Garland, M. L.
Curtin, M. R. Michaelides, J. Li, L. J. Pease, K. B.
Glaser, P. A. Marcotte, J. J. Bouska, S. S. Murphy, S. K.
Davidsen, Bioorg. Med. Chem. Lett. 2002, 12, 3443;
d) R. M. Wadkins, J. L. Hyatt, C. C. Edwards, L. Tsur-
kan, M. R. Redinbo, C. E. Wheelock, P. D. Jones, B. D.
Hammock, P. M. Potter, Mol. Pharmacol. 2007, 71, 713;
e) Y.-M. Shao, W.-B. Yang, T.-H. Kuo, K.-C. Tsai, C.-H.
Lin, A.-S. Yang, P. -H. Liang, C.-H. Wong, Bioorg. Med.
Chem. 2008, 16, 4652.
[16] a) Y. Fukuda, H. Furuta, F. Shiga, Y. Oomori, Y.
Kusama, H. Ebisu, S. Terashima, Bioorg. Med. Chem.
Lett. 1997, 7, 1683; b) Y. Fukuda, H. Furuta, Y.
Kusama, H. Ebisu, Y. Oomori, S. Terashima, J. Med.
Chem. 1999, 42, 1448; c) M. A. Akanmu, C. Songkram,
H. Kagechika, K. Honda, Neurosci. Lett. 2004, 364,
199.
[17] For recent, leading references on 2-trifluoromethyl
indole synthesis, see: a) B. Zhang, A. Studer, Org. Lett.
2014, 16, 1216; b) T. Iqbal, S. Choi, E. Ko, E. J. Cho,
Tetrahedron Lett. 2012, 53, 2005; c) D. A. Nagib,
D. W. C. MacMillan, Nature 2011, 480, 224; d) Z. Chen,
J. Zhu, H. Xie, S. Li, Y. Wu, Y. Gong, Adv. Synth.
Catal. 2011, 353, 325; e) X. Mu, S. Chen, X. Zhen, G.
Liu, Chem. Eur. J. 2011, 17, 6039; f) R. Shimizu, H.
Egami, T. Nagi, J. Chae, Y. Hamashima, M. Sodeoka,
Tetrahedron Lett. 2010, 51, 5947.
[18] Previous examples of Fischer (2-trifluoromethyl)indole
syntheses were limited to free (NH)-indole derivatives:
a) H. Jiang, Y. Wang, W. Wan, J. Hao, Tetrahedron
2010, 66, 2746; b) B. I. Usachev, D. L. Obydennov, V. Y.
Sosnovskikh, J. Fluorine Chem. 2012, 135, 278.
[5] For recent reviews of trifluoromethylation processes,
see: a) T. Furuya, A. S. Kamlet, T. Ritter, Nature 2011,
473, 470; b) O. A. Tomashenko, V. V. Grushin, Chem.
Rev. 2011, 111, 4475; c) Y. MacØ, E. Magnier, Eur. J.
Org. Chem. 2012, 2479; d) N. Shibata, A. Matsnev, D.
Cahard, Beilstein J. Org. Chem. 2010, 6, 65; e) A.
Studer, Angew. Chem. 2012, 124, 9082; Angew. Chem.
Int. Ed. 2012, 51, 8950; f) G. Landelle, A. Panossian, S.
Pazenok, J.-P. Vors, F. R. Leroux, Beilstein J. Org.
Chem. 2013, 9, 2476; g) T. Liang, C. N. Neumann, T.
Ritter, Angew. Chem. 2013, 125, 8372; Angew. Chem.
Int. Ed. 2013, 52, 8214; h) H. Liu, Z. Gu, X. Jiang, Adv.
Synth. Catal. 2013, 355, 617; see also refs.[7,13]
[6] For a review on the chemistry of trifluoromethyl ke-
tones, see: C. B. Kelly, M. A. Mercadante, N. E. Lead-
beater, Chem. Commun. 2013, 49, 11133.
[7] For an exhaustive review of trifluoromethylation reac-
tions involving the Togni reagents, see: J. Charpentier,
N. Früh, A. Togni, Chem. Rev. 2015, 115, 650.
[8] a) E. Pair, N. Monteiro, D. Bouyssi, O. Baudoin,
Angew. Chem. 2013, 125, 5454; Angew. Chem. Int. Ed.
2013, 52, 5346; for an extension of the methodology to
the b-trifluoromethylation of a,b-unsaturated hydra-
zones, see: b) A. Prieto, E. Jeamet, N. Monteiro, D.
Bouyssi, O. Baudoin, Org. Lett. 2014, 16, 4770.
[9] Fluorinated heterocyclic compounds: Synthesis, chemis-
try, and applications (Ed.: V. A.Petrov), 2009, Wiley,
Hoboken.
[10] a) B. Robinson, The Fischer Indole Synthesis, Wiley,
New York, 1982; b) D. L. Hughes, Org. Prep. Proced.
Int. 1993, 25, 607; c) G. R. Humphrey, J. T. Kuethe,
Chem. Rev. 2006, 106, 2875. For a general review of
indole syntheses, see d) D. F. Taber, P. K. Tirunahari,
Tetrahedron 2011, 67, 7195.
[11] For other recent examples of heterocycle synthesis
through cyclization of enolizable hydrazones, see: pyra-
Adv. Synth. Catal. 2015, 357, 2939 – 2943
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2943